Is neoadjuvant treatment indicated in triple negative cT1N0 breast cancer? Garcia-Torralba; Noel Blaya Boluda; María Esperanza Guirao García; Elisa García Garre; Francisco Ayala de la Peña;

Cáncer de mama triple negativo, receptor de andrógeno y otros marcadores. Estrategias terapéuticas Eguia-Larrea; Parra-Perez; Cabero-Moran; Jimenez Rosellon; Munoz-Bellvis;

How can we integrate current adjuvant treatment options in triple negative patients with residual disease after neoadjuvant treatment? Mª. Teresa Quintanar-Verdúguez; María Ballester Espinosa; Javier Pérez-Altozano; Álvaro Muñoz-Abad; Álvaro Rodríguez-Lescure;